Biomerica's InFoods IBS Test Receives PLA Code for Enhanced Reimbursement Access

Biomerica's inFoods IBS test has been granted a PLA code by the American Medical Association's CPT Editorial Panel, enabling claims submissions to Medicare and private insurers starting October 1, 2025. This code serves as a key milestone in Biomerica's commercialization strategy, enhancing reimbursement transparency and expanding patient access. The test identifies specific foods triggering IBS symptoms by detecting elevated immune responses to a panel of common foods, offering personalized dietary guidance to reduce symptom-masking medications and generic elimination diets. Results from a June 2025 Gastroenterology journal clinical trial showed significantly greater symptom improvement in patients following the inFoods-guided diets compared to placebo groups.